Author(s): MacDougald OA, Burant CF
Abstract Share this page
Abstract Chemerin is a newly described adipokine with effects on adipocyte differentiation and metabolism in vitro. Its relationship with body mass index and aspects of the metabolic syndrome suggests a larger role for this protein in obesity-associated complications.
This article was published in Cell Metab
and referenced in Journal of Clinical & Experimental Cardiology